FBXO7 and Parkinson disease: Small-molecule inhibitors of FBXO7 that interfere with the FBXO7–PINK1 interaction reduce mitochondrial injury and inflammation, leading to neuroprotection in primary cortical neurons, human neuroblastoma cells, and PD patient–derived cells (21).